WHO urges increased access to praziquantel as schistosomiasis treatment coverage improves
WHO to fast-track availability of diagnostics for Zika virus
Dracunculiasis surveillance programmes respond strongly to rumours, while cases plummet
Medical Product Alert N°2/2016: Falsified AMARIL yellow fever vaccines
World’s largest deworming campaign targets 270 million children in one day
WHO involvement in Zika R&D
Medical Product Alert N°1/2016: Falsified phenobarbitone tablets
Improved availability of new test to enhance global lymphatic filariasis elimination
WHO welcomes new initiative to combat insecticide resistance
WHO Director-General summarizes the outcome of the Emergency Committee regarding clusters of microcephaly and Guillain-Barré syndrome
